Giuseppe Accogli
Net Worth
Last updated:
What is Giuseppe Accogli net worth?
The estimated net worth of Mr. Giuseppe Accogli is at least $17,331,109 as of 19 Jun 2020. He owns shares worth $1,615,771 as insider, has earned $6,995,338 from insider trading and has received compensation worth at least $8,720,000 in Baxter International Inc..
What is the salary of Giuseppe Accogli?
Mr. Giuseppe Accogli salary is $1,090,000 per year as Executive Vice President & Chief Operating Officer in Baxter International Inc..
How old is Giuseppe Accogli?
Mr. Giuseppe Accogli is 54 years old, born in 1971.
What stocks does Giuseppe Accogli currently own?
As insider, Mr. Giuseppe Accogli owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Baxter International Inc. (BAX) | Executive Vice President & Chief Operating Officer | 66,520 | $24.29 | $1,615,771 |
What does Baxter International Inc. do?
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Giuseppe Accogli insider trading
Baxter International Inc.
Mr. Giuseppe Accogli has made 5 insider trades between 2017-2020, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 72,341 units of BAX stock on 19 Jun 2020. As of 19 Jun 2020 he still owns at least 66,520 units of BAX stock.
Baxter International key executives
Baxter International Inc. executives and other stock owners filed with the SEC:
- Mr. Cristiano Franzi (62) Senior Vice President & Pres for EMEA
- Mr. Giuseppe Accogli (54) Executive Vice President & Chief Operating Officer
- Mr. James K. Saccaro (52) Executive Vice President & Chief Financial Officer
- Mr. Jose E. Almeida (63) Chairman, Pres & Chief Executive Officer
- Mr. Sean B. W. Martin (62) Senior Vice President & Gen. Counsel